
168.20 Delayed Data As of Mar 02 | ![]() Today’s Change | 65.05 Today|||52-Week Range 188.14 | -2.83% Year-to-Date |
Nevro (NVRO) Q4 Loss Narrower Than Estimated, Revenues Miss Feb 25 / Zacks.com - Paid Partner Content | Nevro Corp (NVRO) Q4 2020 Earnings Call Transcript Feb 24 / MotleyFool.com - Paid Partner Content |
Previous close | 168.11 |
Today’s open | 170.29 |
Day’s range | 167.67 - 171.63 |
Volume | 179,843 |
Average volume (3 months) | 355,123 |
Market cap | $5.7B |
Earnings growth (last year) | +26.72% |
Earnings growth (this year) | +10.05% |
Earnings growth (next 5 years) | +13.00% |
Revenue growth (last year) | -7.23% |
P/E ratio | NM |
Price/Sales | 16.10 |
Price/Book | 14.55 |
Today’s change | Today’s % change | |
---|---|---|
TNDMTandem Diabetes Care... | -2.29 | -2.39% |
IRTCiRhythm Technologies... | -3.98 | -2.60% |
LIVNLivaNova PLC | -0.51 | -0.66% |
---- |
Next reporting date | May 10, 2021 |
EPS forecast (this quarter) | -$0.85 |
Annual revenue (last year) | $362.0M |
Annual profit (last year) | -$83.1M |
Net profit margin | -22.94% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Redwood City, California |